Adalimumab: similar safety profile across pediatric indications

  • Horneff G & al.
  • J Pediatr
  • 25 Jul 2018

  • curated by Miriam Davis, PhD
  • Clinical Essentials
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.


  • The most common adverse events (AEs) associated with adalimumab use in children are upper respiratory tract infections, nasopharyngitis, and headache pooled across these indications: juvenile idiopathic arthritis (polyarticular juvenile idiopathic arthritis and pediatric enthesitis-related arthritis), psoriasis, and Crohn's disease.

Why this matters

  • Drug safety profile in pediatric patients, especially across indications, is rare.

Study design

  • Pooled analysis of safety data from 7 international, randomized, and open-label AbbVie-sponsored clinical trials (n=577) and their open-label extensions.
  • AEs occurring after the first dose and up to 70 days after the last dose were analyzed.
  • Funding: AbbVie.

Key results

  • The 577 patients had 1440.7 patient-years (PYs) of exposure.
  • The most commonly reported AEs across indications were upper respiratory tract infections (27% of all patients; 24.3 events/100 PYs), nasopharyngitis (24%; 17.3 events/100 PYs), and headache (24%; 19.9 events/100 PYs).
  • Serious infections were the most common serious AEs, occurring among 8% of all patients (4.0 events/100 PYs).
    • Pneumonia was the single most common serious infection (1%; 0.6 events/100 PYs).
  • Serious infection rates were 2.7 events/100 PYs in juvenile idiopathic arthritis, 0.8 events/100 PYs in psoriasis, and 6.6 events/100 PYs in Crohn's disease.
  • No new safety signals were found.
  • No malignancies were reported.


  • More follow-up needed to assess malignancy risk.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.